According to the state’s public health agency, only 12.7% of eligible people in Tamil Nadu have received the preventive vaccine in the state. The department is concerned that with COVID continuing to swing its claws in the state, people’s failure to get a preventive dose of the vaccine could accelerate the spread.
The ministry is especially concerned about the health status of people at high riskincluding the elderly with comorbidities.
The state’s public health department said that of the 4,05,63,607 people eligible for the booster shot as of August 20, a total of 51,69,621 had self-immunized. This is about 12.74 percent of the eligible population.
A senior official with the state’s public health department told IANS that although the impact of COVID -19 on most people is currently mild, long-term complications related to the disease are not yet known. clearly defined and hence the need for a booster dose for everyone. eligible citizens.
The doctors said that Long-term complications include heart and respiratory problems for people affected by COVID-19.
Dr Suchithra Menon, a virologist at a leading medical university in Madurai, said, “It is almost certain that the COVID-19 virus will persist for a few more years and therefore the dose increases. Strength is essential for those who don’t. to prey on disease that can lead to long-term health complications.”
She said that following COVID-appropriate behaviors, including wearing a mask, keeping a safe distance, and frequent hand hygiene are other key factors that need to be adopted regularly in life to prevent COVID. further spread.
People affected by HIV, TB, high blood pressure and diabetes, are at risk of getting this disease again, and so the Ministry of Health is in the process of raising people’s awareness of the need for vaccinations. strains.
Doctors also said the health ministry is also planning to encourage youth to conduct house-to-house awareness about the need for booster shots or preventive doses of the COVID vaccine to prevent further spread. of epidemics.